Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Unknown 3Completed 3Active not recruiting 2

Sponsor Class

OTHER 2UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Non-Small-Cell Lung 14Small Cell Lung Carcinoma 7Carcinoma, Hepatocellular 7Urinary Bladder Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Melanoma 4Lung Neoplasms 4Head and Neck Neoplasms 4Biliary Tract Neoplasms 4Rectal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Renal Cell 3Stomach Neoplasms 2Recurrence 2Pancreatic Neoplasms 2Mesothelioma, Malignant 2Lymphoma 2Liver Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Cholangiocarcinoma 2Carcinoma, Transitional Cell 2Carcinoma, Merkel Cell 2Bile Duct Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Unresectable Stage III NSCLC 1Triple Negative Breast Neoplasms 1Resectable Biliary Tract Cancer 1Radiation Pneumonitis 1

Interventions

Cisplatin 28Paclitaxel 19Radiotherapy 17Fluorouracil 13Drug Therapy 12camrelizumab 10toripalimab 8Carboplatin 8Radiation 7Capecitabine 7Radiotherapy, Intensity-Modulated 6sintilimab 5S 1 (combination) 5Esophagectomy 5tislelizumab 4nimotuzumab 4apatinib 4anlotinib 4Irinotecan 4Cetuximab 4Afatinib 4pembrolizumab 3durvalumab 3Vinorelbine 3Positron Emission Tomography Computed Tomography 3Oxaliplatin 3Nivolumab 3Immune Checkpoint Inhibitors 3Docetaxel 3Albumin-Bound Paclitaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Esophageal Squamous Cell Carcinoma × durvalumab × Clear all
NCT04851132 2021-06-22

Radiotherapy Plus Durvalumab in Elderly Esophageal Squamous Cell Carcinoma

ChineseAMS

Phase NA Unknown
33 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03377400 2020-12-17

Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal Cancer

Samsung Medical Center

Phase 2 Unknown
40 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04054518 2019-08-13

DESC

Instituto do Cancer do Estado de São Paulo

Phase 2 Unknown
22 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡